Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

donor-derived cytokine-induced memory-like natural killer cells

A population of donor-derived cytokine-induced, memory-like, cytotoxic natural killer (NK) cells (CIML NKs), with potential antitumor activity. Allogeneic NK cells are pre-activated ex vivo with various cytokines, which induces the differentiation of the NK cells into CIML NK cells. The pretreated NK cells exhibit enhanced activation and interferon-gamma (IFN-g) responses, and may exert enhanced cytotoxicity against tumor cells. Upon administration, the CIML NKs may induce an anti-tumor immune response and kill tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic CIML NK cells
allogeneic CIML NKs
allogeneic cytokine-induced memory-like NK cell
CIML-NK cells
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search